Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,854 | 1,091 | 1,447 | 1,159 | 2,248 |
| Receivables | 49,559 | 65,276 | 61,956 | 41,430 | 69,577 |
| Inventories | 73,700 | 79,433 | 69,415 | 63,076 | 76,779 |
| Other current assets | 0 | 0 | 0 | 37,618 | 0 |
| TOTAL | $132,037 | $154,521 | $142,409 | $148,321 | $162,927 |
| Non-Current Assets | |||||
| PPE Net | 123,209 | 179,929 | 180,460 | 112,770 | 168,693 |
| Investments And Advances | 0 | 0 | 0 | 0 | 45,100 |
| Intangibles | 58,492 | 72,456 | 105,009 | 59,548 | 106,002 |
| Other Non-Current Assets | 11,844 | 15,218 | 17,741 | 182,285 | 27,101 |
| TOTAL | $193,545 | $267,603 | $303,210 | $354,603 | $346,896 |
| Total Assets | $325,582 | $422,124 | $445,619 | $502,924 | $509,823 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 39,900 | 42,000 | 32,000 | 29,000 | 41,000 |
| Accounts payable and accrued liabilities | 20,014 | 59,098 | 46,355 | 16,298 | 56,323 |
| Accrued Expenses | 9,757 | 7,214 | 9,173 | 7,754 | 11,218 |
| TOTAL | $90,065 | $122,264 | $103,653 | $101,888 | $125,349 |
| Non-Current Liabilities | |||||
| Long Term Debt | 79,598 | 124,194 | 123,833 | 164,902 | 145,051 |
| Deferred Revenues | 1,614 | 1,160 | 1,216 | 637 | 1,595 |
| Other Non-Current Liabilities | 10,886 | 18,097 | 20,177 | 27,210 | 28,191 |
| TOTAL | $91,445 | $143,658 | $148,101 | $198,252 | $179,850 |
| Total Liabilities | $181,510 | $265,922 | $251,754 | $300,140 | $305,199 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,483 | 29,481 | 29,462 | N/A | 29,333 |
| Common Shares | 29 | 29 | 29 | 29 | 29 |
| Retained earnings | -22,188 | -9,338 | 29,103 | 38,580 | 41,446 |
| Other shareholders' equity | -712 | -816 | -992 | -1,358 | -1,716 |
| TOTAL | $144,072 | $156,202 | $193,865 | $202,784 | $204,624 |
| Total Liabilities And Equity | $325,582 | $422,124 | $445,619 | $502,924 | $509,823 |